Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 41: 1455-1460, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Willemsen, J. J.
Right arrow Articles by Benraad, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Willemsen, J. J.
Right arrow Articles by Benraad, T. J.

Clinical Chemistry, Vol 41, 1455-1460, Copyright © 1995 by American Association for Clinical Chemistry

Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans

JJ Willemsen, HA Ross, MC Jacobs, JW Lenders, T Thien, LM Swinkels and TJ Benraad
Department of Experimental and Chemical Endocrinology, Academic Hospital St. Raboud, University of Nijmegen, The Netherlands.

An HPLC separation method combined with fluorometric detection was extended to enable simultaneous assessment of plasma 3H-labeled and endogenous epinephrine (E) and norepinephrine (NE). Forearm fractional extraction (FFE) of 3H-labeled E and NE and of endogenous E was measured in 40 healthy volunteers who were receiving a continuous infusion of 3H-labeled E and NE. Concentrations of arterial and venous E were 26.8 +/- 1.95 (mean +/- SE) and 6.8 +/- 0.75 ng/L, respectively. Arterial and venous NE and dopamine (DA) were also measured, with respective values of 140.7 +/- 8.5 and 192.1 +/- 15.1 for NE, and 13.1 +/- 0.78 and 11.3 +/- 0.70 ng/L for DA. The FFE of 3H-labeled E was slightly but significantly higher (0.790 +/- 0.016) than the that of either 3H-labeled NE or endogenous E (0.748 +/- 0.0146 and 0.745 +/- 0.0185, respectively; P < 0.001), the correlations being highly significant (r = 0.80, P < 0.001) in both cases. The small difference between the FFE of E and of 3H-labeled E allows the calculation of the apparent spillover of E. However, this spillover was negligible compared with forearm NE spillover (0.0112 +/- 0.0031 vs 1.369 +/- 0.128 ng/L per minute. The high sensitivity of this measurement of venous E widens the possibilities for studying E kinetics under physiological conditions.


The following articles in journals at HighWire Press have cited this article:


Home page
HypertensionHome page
J. Tank, K. Heusser, A. Diedrich, R. J. Brychta, F. C. Luft, and J. Jordan
Yohimbine Attenuates Baroreflex-Mediated Bradycardia in Humans
Hypertension, November 1, 2007; 50(5): 899 - 903.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. J. Willemsen, H. A. Ross, J. W.M. Lenders, and F. C.G.J. Sweep
Stability of Urinary Fractionated Metanephrines and Catecholamines during Collection, Shipment, and Storage of Samples
Clin. Chem., February 1, 2007; 53(2): 268 - 272.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. A. Ross, P. J. van Gurp, J. J. Willemsen, J. W. M. Lenders, C. J. Tack, and F. C. G. J. Sweep
Transport within the Interstitial Space, Rather Than Membrane Permeability, Determines Norepinephrine Recovery in Microdialysis
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 840 - 846.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Masuo, T. Katsuya, Y. Fu, H. Rakugi, T. Ogihara, and M. L. Tuck
{beta}2- and {beta}3-Adrenergic Receptor Polymorphisms Are Related to the Onset of Weight Gain and Blood Pressure Elevation Over 5 Years
Circulation, June 28, 2005; 111(25): 3429 - 3434.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J.M.J. Smeenk, C.M. Verhaak, A.J.J.M. Vingerhoets, C.G.J. Sweep, J.M.W.M. Merkus, S.J. Willemsen, A. van Minnen, H. Straatman, and D.D.M. Braat
Stress and outcome success in IVF: the role of self-reports and endocrine variables
Hum. Reprod., April 1, 2005; 20(4): 991 - 996.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. E. de Galan, C. J. Tack, J. J. Willemsen, C. G. J. Sweep, P. Smits, and J. W. M. Lenders
Plasma Metanephrine Levels Are Decreased in Type 1 Diabetic Patients with a Severely Impaired Epinephrine Response to Hypoglycemia, Indicating Reduced Adrenomedullary Stores of Epinephrine
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2057 - 2061.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. E. de Galan, S. J. Rietjens, C. J. Tack, S. P. van der Werf, C. G. J. Sweep, J. W. M. Lenders, and P. Smits
Antecedent Adrenaline Attenuates the Responsiveness to But Not the Release of Counterregulatory Hormones during Subsequent Hypoglycemia
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5462 - 5467.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. E. de Galan, C. J. Tack, J. W. Lenders, J. W. Pasman, L. D. Elving, F. G. Russel, J. A. Lutterman, and P. Smits
Theophylline Improves Hypoglycemia Unawareness in Type 1 Diabetes
Diabetes, March 1, 2002; 51(3): 790 - 796.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. B. Keijzers, B. E. De Galan, C. J. Tack, and P. Smits
Caffeine Can Decrease Insulin Sensitivity in Humans
Diabetes Care, February 1, 2002; 25(2): 364 - 369.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Kavelaars, W. Kuis, L. Knook, G. Sinnema, and C. J. Heijnen
Disturbed Neuroendocrine-Immune Interactions in Chronic Fatigue Syndrome
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 692 - 696.
[Abstract] [Full Text]


Home page
HypertensionHome page
G. Vervoort, J. F. Wetzels, J. A. Lutterman, L. G. van Doorn, J. H. Berden, and P. Smits
Elevated Skeletal Muscle Blood Flow in Noncomplicated Type 1 Diabetes Mellitus : Role of Nitric Oxide and Sympathetic Tone
Hypertension, November 1, 1999; 34(5): 1080 - 1085.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Adam, M. Bouvier, and T. L. Z. Jones
Nitric Oxide Modulates beta 2-Adrenergic Receptor Palmitoylation and Signaling
J. Biol. Chem., September 10, 1999; 274(37): 26337 - 26343.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
M. L. Peters, G. L. R. Godaert, R. E. Ballieux, J. F. Brosschot, F. C. G. J. Sweep, L. M. J. W. Swinkels, M. van Vliet, and Cobi. J. Heijnen
Immune Responses to Experimental Stress: Effects of Mental Effort and Uncontrollability
Psychosom Med, July 1, 1999; 61(4): 513 - 524.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M.-C. Jacobs, J. W. M. Lenders, J. J. Willemsen, and T. Thien
Adrenomedullary Secretion of Epinephrine Is Increased in Mild Essential Hypertension
Hypertension, June 1, 1997; 29(6): 1303 - 1308.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.